INTRODUCTION
Familial adenomatous polyposis (FAP) is a hereditary neoplastic syndrome caused by mutation in genes APC (adenomatous polyposis coli) or MUTYH (mutY DNA glykosylase) -numerous colorectal adenomas are the main phenotypic feature. Although the disease is responsible for less than 1% of colorectal cancer cases in overall population, affected individual is exposed to almost absolute risk of colorectal cancer and various extracolonic neoplasias and other manifestations, frequently in young age. Prophylactic colectomy remains the only way to reduce mortality for colorectal cancer, despite some effect of chemoprophylaxis (e.g. coxibs). The person must undergo lifelong follow-up including endoscopic examinations to control risk of extracolonic malignancies, especially duodenal and desmoid tumours. Disease and/or prophylactic operation have a significant impact on patient's quality of life. Affected individual and his/her families need specialized care based on interdisciplinary cooperation organized within regional, national and international networks.
HISTORY AND SIGNIFICANCE OF FAP REGISTRATION
First FAP register was founded in St. Mark's hospital, London by pathologist Cuthbert Dukes, surgeon J. P. Lockhart-Mummery and assistant H. J. R. Bussey (1) . According to systematic review of studies, registration and screening result in reduction of colorectal cancer incidence and mortality in patients with FAP (and Lynch syndrome) (2) . FAP registries provide many additional benefits: organisational, patient-focused and research-focused. Majority of western countries runs its own FAP registries. InSiGHT (International Society for Gastrointestinal Hereditary Tumours) currently covers these activities on international bases (3). Educational activities towards patients and their families were an additional task of the working group: Instruction leaflet for patients and their families were prepared in 2010 by Assoc. prof. Václav Jirásek and geneticist Jaroslav Kotlas, M.D. (5) . Web pages with internet discussion forum for patients ran since 2010 on www.polyposy.cz (6) .
HISTORY OF FAP REGISTRATION IN CZECH REPUBLIC

PRESENT AND FUTURE OF FAP REGISTRATION IN CZECH REPUBLIC
Presentation of single centre results on abovementioned national gastroenterology meetings in 2015-16 represented the maximum achievable with existing register format with limited participation. Thus when Ministry of Health of Czech Republic announced National action plan for rare diseases, we claimed for this grant on the platform of Czech Society of Gastroenterology as a part of Czech Medical Association of J. E. Purkyně. Priority 3b of the Developing project is dedicated to generation and run of registries of rare diseases. Administration of the database came back under the wings of Institute of Biostatistics and Analysis of Masaryk University (IBA spin-off), which is the major provider of database medical services in Czech Republic. Primary network was formed by 5 centres involved in care of FAP patients (Military University Hospital Prague, General University Hospital Prague, ISCARE centre Prague, Masaryk Memorial Cancer Institute Brno and Faculty hospital Hradec Králové). Resources were definitely allocated in August 2016 and enabled to innovate existing database structure, tune the online interface with active participation of all engaged centres. Simultaneously we applied for the same grant for 2017. Our long-term goal is sustainable cooperation within current platform, which will be able to run register and thus to fulfil all clinical tasks of registration process including generation of adequate long-term results.
